Filing Flows › Rapid Micro Biosystems (RPID) › Q2 2025
Rapid Micro Biosystems (RPID) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Rapid Micro Biosystems (RPID) reported revenue of $7.3M for the second quarter 2025 (Q2 2025), +10% from a year earlier and +0.8% from the quarter before. Operating margin was -167.3%, net loss $11.9M (163.3% of revenue).
Rapid Micro Biosystems, Q2 2025: revenue $7.3M (+10% year over year), operating margin -167.3%, net loss $11.9M, operating cash flow −$9.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.3M | +0.8% | +10% |
| Operating profit | −$12.1M | — | — |
| Net earnings | −$11.9M | — | — |
| Operating cash flow | −$9.7M | — | — |
What changed
Revenue was $7.3M in Q2 2025, up 10% year over year and up 1% from the previous quarter. Product was the largest line at 66% of revenue. Service added $379K year over year (up 18%), 59% of the total change.
Gross margin was 3.8%. Operating costs exceeded revenue by $12.1M, an operating margin of -167.3%. The quarter ended with a net loss of $11.9M, wider than the previous quarter's $11.3M loss.
Operating cash flow was −$9.7M. Non-cash charges added back $811K of depreciation and amortization and $1.2M of share-based compensation. Capital expenditures of $366K exceeded it, leaving free cash flow of −$10.1M.
Questions
What was Rapid Micro Biosystems' revenue in the second quarter 2025?
Rapid Micro Biosystems (RPID) reported revenue of $7.3M for the second quarter 2025 (Q2 2025), +10% from a year earlier and +0.8% from the quarter before.
Was Rapid Micro Biosystems profitable in the second quarter 2025?
Operating loss was $12.1M (-167.3% of revenue) and net loss $11.9M.